Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organon & Co. (OGN : NYSE)

• Company Description    Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. Number of Employees: 10,000

• Price / Volume Information    Yesterday's Closing Price: $13.43 Daily Weekly Monthly 20 Day Moving Average: 15,842,622 shares Shares Outstanding: 262.60 (millions) Market Capitalization: $3,526.73 (millions) Beta: 1.57 52 Week High: $13.48 52 Week Low: $5.69 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 56.16% 48.53% 12 Week 85.75% 71.72% Year To Date 87.31% 72.08%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 30 Hudson Street FL 33 - Jersey City,NJ 07302 USA ph: 551-430-6900 fax: - investor_relations@organon.com http://www.organon.com

• General Corporate Information    Officers Joseph Morrissey - Interim Chief Executive Officer Carrie Cox - Executive Chair of the Board Matthew Walsh - Chief Financial Officer Lynette Holzbaur - Senior Vice President Finance - Corporate Controll Alan Ezekowitz - Director Peer Information Organon & Co. (CHCR) Organon & Co. (ESRX) Organon & Co. (MYDP) Organon & Co. (COR) Organon & Co. (GBCS) Organon & Co. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 68622V106 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 262.60 Most Recent Split Date: (:1) Beta: 1.57 Market Capitalization: $3,526.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.60% Current Fiscal Quarter EPS Consensus Estimate: $0.85 Indicated Annual Dividend: $0.08 Current Fiscal Year EPS Consensus Estimate: $3.22 Payout Ratio: 0.03 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: -0.17 Estmated Long-Term EPS Growth Rate: 3.35% Last Dividend Paid: 05/11/2026 - $0.04 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: 4.16 Trailing 12 Months: 4.28 PEG Ratio: 1.24 Price Ratios Price/Book: 3.91 Price/Cash Flow: 2.32 Price / Sales: 0.57 EPS Growth vs. Year Ago Period: -30.53% vs. Previous Quarter: 8.20% Sales Growth vs. Year Ago Period: -3.50% vs. Previous Quarter: -3.12% ROE 03/31/26 - 99.95 12/31/25 - 122.01 09/30/25 - 143.47 ROA 03/31/26 - 6.22 12/31/25 - 6.74 09/30/25 - 7.14 Current Ratio 03/31/26 - 1.97 12/31/25 - 1.82 09/30/25 - 1.75 Quick Ratio 03/31/26 - 1.42 12/31/25 - 1.23 09/30/25 - 1.20 Operating Margin 03/31/26 - 13.35 12/31/25 - 14.39 09/30/25 - 15.10 Net Margin 03/31/26 - 3.99 12/31/25 - 3.01 09/30/25 - 7.95 Pre-Tax Margin 03/31/26 - 8.71 12/31/25 - 6.84 09/30/25 - 11.14 Book Value 03/31/26 - 3.44 12/31/25 - 2.89 09/30/25 - 3.49 Inventory Turnover 03/31/26 - 2.03 12/31/25 - 2.03 09/30/25 - 2.01 Debt-to-Equity 03/31/26 - 9.47 12/31/25 - 11.47 09/30/25 - 9.69 Debt-to-Capital 03/31/26 - 90.45 12/31/25 - 91.98 09/30/25 - 90.65

Powered by Zacks Investment Research ©